Abstract 4343703: A murine model of cardiovascular-kidney-metabolic syndrome demonstrates compromised limb function in the ischemic hind limb
Abstract
Background: Cardiovascular-Kidney-metabolic (CKM) syndrome is a public health problem in the US and results in premature CVD at a relatively preserved GFR. The molecular mediators of CKM are poorly understood, partly due to the lack of a reliable animal model. We set out to generate an animal model with renal and metabolic dysfunctions, using peripheral arterial disease (PAD) as a CKM manifestation. Methods: C57BL/6 male and female mice were randomized into four groups: a normal diet (ND, controls), a 0.2% adenine diet (AD, a CKD model), a high-fat diet (HFD, a metabolic model), and a combination of HFD+AD (a potential CKM model). The mice underwent a hind limb ischemia, followed by structural, endurance, and post-exercise hyperemia assays. Results: Compared to control mice, HFD+AD male mice had 23-50% higher weight and GFR than the AD group (P = 0.003). The kidneys of HFD+AD showed tubular atrophy, tubulointerstitial fibrosis, immune infiltration, glomerulomegaly, consistent with glomerular hyperperfusion, hypercholesterolemia, impaired glucose tolerance, and adipophilin in the liver, an early marker of hepatic steatosis, and myocardial fibrosis. The HFD+AD mice showed reduced hind limb perfusion ratios, microcapillary density, Type II muscle fibers, and increased muscle fibrosis, immune infiltration, and the lowest cross-sectional muscle area. Female CKM mice revealed distinct differences from male mice. Compared to AD and HFD alone, female CKM mice exposed to HFD+AD demonstrated additive phenotypes in endurance assays (distance travelled, exhaustion time and grip strength) without a similar effect in post-ischemia perfusion, suggesting skeletal muscle and microcapillary dysfunction. Conclusion: A combination of HFD+AD in mice displays CKD, metabolic disorders, and cardiovascular disease features at a higher GFR, consistent with human CKM. This model can be explored to probe the mechanisms, heterogeneity, and sex-specific differences in CKM.
Article Details
Authors (6)
Saran Lotfollahzadeh
Jeffrey Siracuse
Boston University, Chestnut Hill, Massachusetts, United States
Howard Cabral
Boston University, Boston, Massachusetts, United States
Marina Malikova
Boston University School of Medicin, Boston, Massachusetts, United States
Nazish Sayed
Stanford Cardiovascular Institute, CA (D.T., A.M., Y.L., R.V., N.B., S.R.Z., C.J., I.Y.C., N.S., J.C.W.).
Vipul Chitalia